PKIA Protein (Transcript Variant 6) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2729031

This Recombinant PKIA protein is produced in HEK-293 Cells.

Quick Overview for PKIA Protein (Transcript Variant 6) (Myc-DYKDDDDK Tag) (ABIN2729031)

Target: PKIA (Protein Kinase (CAMP-Dependent, Catalytic) Inhibitor alpha (PKIA))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 6

Purification tag / Conjugate: This PKIA protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human PKIA (transcript variant 6) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: PKIA (Protein Kinase (CAMP-Dependent, Catalytic) Inhibitor alpha (PKIA))

Alternative Name: Pkia

Background: Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. [UniProtKB/Swiss-Prot Function]

Molecular Weight: 7.8 kDa

NCBI Accession: NP_006814

Pathways: Myometrial Relaxation and Contraction